Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Orgenesis Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 21 | 18 | −3 |
| Shares | 2.20M | 2.21M | +11.8K (+0.5%) |
| Value | $1.10M | $1.82M | +$716.9K (+65.1%) |
New holders (3)
Institutions that held Orgenesis Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Redwood Financial Network Corp | 25,000 | $20.6K | 0.02% |
| Capital Advisors, Ltd. LLC | 852 | $1.00K | 0.00% |
| Royal Bank of Canada | 104 | $0 | 0.00% |
Sold out (6)
Institutions that held Orgenesis Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Jane Street Group, LLC | 11,998 | $6.01K |
| XTX Topco Ltd | 11,774 | $5.89K |
| Prudential Financial Inc | 11,000 | $5.51K |
| TSFG, LLC | 1,092 | $1.00K |
| UBS Group AG | 1,100 | $551 |
| Morgan Stanley | 38 | $19 |